These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3297625)

  • 1. Teratology of the antituberculosis drugs.
    Holdiness MR
    Early Hum Dev; 1987 Mar; 15(2):61-74. PubMed ID: 3297625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact dermatitis to antituberculosis drugs.
    Holdiness MR
    Contact Dermatitis; 1986 Nov; 15(5):282-8. PubMed ID: 3545669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of tuberculosis during pregnancy.
    Snider DE; Layde PM; Johnson MW; Lyle MA
    Am Rev Respir Dis; 1980 Jul; 122(1):65-79. PubMed ID: 6996549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antituberculous drugs.
    Warkany J
    Teratology; 1979 Aug; 20(1):133-7. PubMed ID: 92814
    [No Abstract]   [Full Text] [Related]  

  • 5. The side effects and interactions of antituberculosis drugs.
    Addington WW
    Chest; 1979 Dec; 76(6 Suppl):782-4. PubMed ID: 510025
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effects of antituberculosis drugs.
    Girling DJ
    Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse effects of antituberculosis drugs causing changes in treatment.
    Gonzalez Montaner LJ; Dambrosi A; Manassero M; Dambrosi VM
    Tubercle; 1982 Dec; 63(4):291-4. PubMed ID: 6926784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological manifestations and toxicities of the antituberculosis drugs. A review.
    Holdiness MR
    Med Toxicol; 1987; 2(1):33-51. PubMed ID: 3547005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apoptosis-inducing action of antituberculosis drugs of the main group in vitro].
    Vasilyeva OA; Serebryakova VA; Urazova OI; Novitsky VV; Kononova TE; Naslednikova IO
    Antibiot Khimioter; 2010; 55(11-12):25-9. PubMed ID: 21574422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance and complications of antituberculosis chemotherapy].
    Duroux P
    Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779
    [No Abstract]   [Full Text] [Related]  

  • 12. A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy.
    Czeizel AE; Rockenbauer M; Olsen J; Sørensen HT
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):564-8. PubMed ID: 11409585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of antitubercular drugs and significance of measurement of the drug-stimulating lymphocyte transformation rate.
    Umeki S
    Jpn J Med; 1989; 28(3):335-40. PubMed ID: 2739142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse cutaneous reactions to antituberculosis drugs.
    Holdiness MR
    Int J Dermatol; 1985 Jun; 24(5):280-5. PubMed ID: 2410379
    [No Abstract]   [Full Text] [Related]  

  • 15. Side effects of drugs used to treat tuberculosis.
    Newton RW
    Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648
    [No Abstract]   [Full Text] [Related]  

  • 16. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 17. Antituberculosis agents: isoniazid, rifampin, streptomycin, ethambutol.
    Van Scoy RE
    Mayo Clin Proc; 1977 Nov; 52(11):694-700. PubMed ID: 926845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antituberculous drugs and pregnancy (author's transl)].
    Mulliez N; Youssef S; Galliot-Logeay B; Roux C
    Therapie; 1981; 36(5):503-10. PubMed ID: 6172877
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for hepatotoxicity induced by antituberculosis drugs.
    Devoto FM; González C; Iannantuono R; Serra HA; González CD; Sáenz C
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(4):197-202. PubMed ID: 9504179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
    Levantine A; Almeyda J
    Br J Dermatol; 1972 Jun; 86(6):651-5. PubMed ID: 4114691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.